Tampere, Finland

Inion Ltd.

Calculating rank
USPTO Granted Patents = 9

% Expired Patents = 55.6

Trademarks = 1

Forward Citations = 637

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Timo Pohjonen (5 out of 19 patents)

silverMedal Auvo Kaikkonen (5 out of 13 patents)

bronzeMedal Jan Nieuwenhuis (5 out of 8 patents)

4.  Harri Happonen (4 out of 11 patents)

5.  Eija Pirhonen (3 out of 7 patents)

6.  Franz Weber (2 out of 7 patents)

7.  Pia Ahvenjärvi (2 out of 2 patents)

8.  Loredana Moimas (1 out of 2 patents)

9.  Hermann Sailer (1 out of 4 patents)

10.  Timo Reunämaki (1 out of 1 patent)

11.  Olli Karhi (1 out of 4 patents)

12.  Timo Reunamäki (1 out of 1 patent)

13.  Jukka Koljonen (1 out of 1 patent)

14.  Andreas Pösel (1 out of 1 patent)

15.  Tuomo Nieminen (1 out of 1 patent)


9 patents:

Company Overview
Inion Ltd. is a leading medical device company specializing in bioresorbable implants for orthopedic and craniofacial surgeries. With a focus on innovation and quality, Inion has developed a range of cutting-edge products that offer superior performance and patient outcomes. Founded in 1999, Inion continues to be at the forefront of the medical industry, providing solutions that improve the lives of patients worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 17 2026

Inion Ltd. USPTO Patent Assignee Logo
9 Patents

#28 in Tampere

#326 in Finland

Tampere, FI
Tampere, Finland
Forward Citations = 637

18 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Inion Ltd.. Retrieved from https://idiyas.com/company/inion

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…